検索結果 - O. Albanyan

P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY 著者: O. Albanyan, O. Castaneda-Puglianini, J. Chavez

全文の入手

Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis. 著者: A Alshabanat, Z Zafari, O Albanyan, M Dairi, J M FitzGerald

全文の入手

P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT 著者: O. Albanyan, D. Kalos, J. Kim, R. Faramand, H. Elmariah, A. Mishra, T. Nishihori, L. Perez, M. Nieder, J. Pidala, N. Bejnayan

全文の入手

P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT SURVIVAL OUTCOMES AFTER CD19-DIRECTED CAR T-CELL THERAPY FOR R/R LBCL 著者: K. Rejeski, O. Albanyan, G. Iacoboni, V. Bücklein, V. Blumenberg, O. Penack, W. Bethge, S. Völkl, A. Perez, C. Carpio, C. Schmidt, N. Müller, K. Reid, R. Faramand, M. Davila, L. Bullinger, F. Locke, M. von Bergwelt-Baildon, A. Mackensen, P. Barba, M. Jain, M. Subklewe

全文の入手

P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CH... 著者: V. Bücklein, A. Perez, G. Iacoboni, K. Rejeski, U. Holtick, O. Penack, S. Kharboutli, V. Blumenberg, J. Ackermann, L. Frölich, G. Johnson, K. Patel, B. Arciola, C. Schmidt, O. Albanyan, P. Gödel, E. Hoster, L. Bullinger, A. Mackensen, F. Locke, M. von Bergwelt, P. Barba, M. D. Jain, M. Subklewe

全文の入手